Black Rock Inc. Hutchmed (China) LTD Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Black Rock Inc. holds 17,349 shares of HCM stock, worth $309,159. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,349

Previous 23,524 26.25%

Holding current value

$309,159

Previous $426,000 31.69%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$12.08 - $18.56 $74,594 - $114,607	-6,175 Reduced 26.25%	17,349 $291,000
Q4 2023 Feb 13, 2024	SELL	$16.25 - $20.23 $225,225 - $280,387	-13,860 Reduced 37.07%	23,524 $426,000
Q3 2023 Nov 13, 2023	SELL	$11.85 - $16.95 $731,784 - $1.05 Million	-61,754 Reduced 62.29%	37,384 $633,000
Q2 2023 Aug 11, 2023	SELL	$10.78 - $17.73 $899,170 - $1.48 Million	-83,411 Reduced 45.69%	99,138 $1.19 Million
Q1 2023 May 12, 2023	BUY	$13.02 - $19.87 $418,723 - $639,019	32,160 Added 21.38%	182,549 $2.38 Million

Q4 2022 Feb 13, 2023	SELL	$7.65 - $15.51 $27.6 Million - $55.9 Million	-3,601,394 Reduced 95.99%	150,389 $2.22 Million
Q3 2022 Nov 14, 2022	SELL	$8.63 - $15.52 $609,139 - $1.1 Million	-70,584 Reduced 1.85%	3,751,783 $33.2 Million
Q2 2022 Aug 12, 2022	BUY	$8.59 - $20.77 $2.63 Million - $6.35 Million	305,782 Added 8.7%	3,822,367 $48.3 Million
Q1 2022 May 12, 2022	BUY	$15.52 - $35.65 $1.92 Million - $4.4 Million	123,396 Added 3.64%	3,516,585 $66.5 Million
Q4 2021 Feb 10, 2022	SELL	$28.89 - $35.33 $2.01 Million - $2.46 Million	-69,586 Reduced 2.01%	3,393,189 $119 Million
Q3 2021 Nov 09, 2021	BUY	$35.66 - $42.94 $16 Million - $19.3 Million	448,350 Added 14.87%	3,462,775 $127 Million
Q2 2021 Aug 11, 2021	BUY	$23.7 - $39.27 $71.4 Million - $118 Million	3,014,425 New	3,014,425 $118 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

14M

Call Options Held

2.7K

Put Options Held

3.7K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.08B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account